Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study

被引：0
|
作者：
Mathilde Fraty
Gilberto Velho
Elise Gand
Fréderic Fumeron
Stéphanie Ragot
Philippe Sosner
Kamel Mohammedi
Barnabas Gellen
Pierre-Jean Saulnier
Jean-Michel Halimi
David Montaigne
Grégory Ducrocq
Michaela Rehman
Michel Marre
Ronan Roussel
Samy Hadjadj
机构：
[1] CHU de Poitiers,Centre d’Investigation Clinique
[2] CHU de Poitiers,Service d’Endocrinologie
[3] Centre de Recherche des Cordeliers,Diabétologie
[4] Inserm UMR_S 1138,Pole DUNE (Digestif, Urologie, Néphrologie, Endocrinologie)
[5] CHU de Poitiers,Laboratoire MOVE (EA 6314), Faculté des Sciences du Sport
[6] UFR de Médecine,Service de Cardiologie
[7] Université Paris Diderot,Service Néphrologie, Dialyse et Transplantation
[8] Sorbonne Paris Cité,Clinique de Physiologie et Département d’Échocardiographie
[9] UFR de Médecine et Pharmacie,Service de Cardiologie
[10] Université de Poitiers,undefined
[11] CIC 1402,undefined
[12] Inserm Poitiers,undefined
[13] Centre médico-sportif MON STADE,undefined
[14] Centre de Diagnostic et de Thérapeutique,undefined
[15] AP-HP Hôpital Universitaire Hôtel-Dieu,undefined
[16] Université de Poitiers,undefined
[17] Service Endocrinologie,undefined
[18] Diabétologie,undefined
[19] Nutrition,undefined
[20] Hôpital Haut Lévêque,undefined
[21] CHU de Bordeaux,undefined
[22] Polyclinique de Poitiers,undefined
[23] CHU de Tours,undefined
[24] Inserm CIC0202,undefined
[25] CHRU Lille,undefined
[26] Inserm U1011,undefined
[27] EGID,undefined
[28] Institut Pasteur de Lille,undefined
[29] Université de Lille,undefined
[30] Service de Cardiologie,undefined
[31] AP-HP,undefined
[32] Hôpital Bichat Claude Bernard,undefined
[33] CHU de Poitiers,undefined
[34] Service de Diabétologie,undefined
[35] Endocrinologie et Nutrition,undefined
[36] DHU FIRE,undefined
[37] AP-HP,undefined
[38] Hôpital Bichat Claude Bernard,undefined
来源：
Diabetologia | 2018年 / 61卷
关键词：
Adrenomedullin; Biomarkers; BNP; Heart failure; NT-proBNP; Prognosis; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2643 / 2653
页数：10
相关论文
共 50 条
  • [11] New cardiovascular biomarkers in patients with advanced cancer - A prospective study comparing MR-proADM, MR-proANP, copeptin, high-sensitivity troponin T and NT-proBNP
    Anker, Markus S.
    Lueck, Laura C.
    Khan, Muhammad Shahzeb
    Porthun, Jan
    Hadzibegovic, Sara
    Lena, Alessia
    Wilkenshoff, Ursula
    Weinlaender, Pia
    Evertz, Ruben
    Totzeck, Matthias
    Mahabadi, Amir A.
    Rassaf, Tienush
    Anker, Stefan D.
    Bullinger, Lars
    Keller, Ulrich
    Karakas, Mahir
    Landmesser, Ulf
    Butler, Javed
    von Haehling, Stephan
    EUROPEAN JOURNAL OF HEART FAILURE, 2024,
  • [12] NT-proBNP cut-off value for ruling out heart failure in atrial fibrillation patients-A prospective clinical study
    Budolfsen, Cecilie
    Schmidt, Anders Sjorslev
    Lauridsen, Kasper Glerup
    Hoeks, Camilla Bang
    Waziri, Farhad
    Poulsen, Christian Bo
    Riis, Dung Nguyen
    Rickers, Hans
    Lofgren, Bo
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2023, 71 : 18 - 24
  • [13] Short-Term Influence of Radiofrequency Ablation on NT-proBNP, MR-proANP, Copeptin, and MR-proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study
    Charitakis, Emmanouil
    Walfridsson, Akan
    Alehagen, Urban
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (09):
  • [14] NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure
    Vergaro, Giuseppe
    Januzzi, James L., Jr.
    Solal, Alain Cohen
    Aimo, Alberto
    Arzilli, Chiara
    Zyw, Luc
    Valleggi, Alessandro
    Giannoni, Alberto
    Prontera, Concetta
    Barison, Andrea
    Poletti, Roberta
    Gabutti, Alessandra
    Mammini, Chiara
    Passino, Claudio
    Emdin, Michele
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 271 : 324 - 330
  • [15] Prognostic value of pathogenetic therapy-induced changes in NT-proBNP in patients with chronic heart failure
    Mezhonov, E. M.
    Shalayev, S. V.
    TERAPEVTICHESKII ARKHIV, 2012, 84 (09) : 71 - 75
  • [16] Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction
    Huang, Anan
    Qi, Xin
    Hou, Wenguang
    Qi, Yanfang
    Zhao, Na
    Liu, Keqaing
    ACTA CARDIOLOGICA, 2018, 73 (01) : 41 - 48
  • [17] Sex differences in the diagnostic algorithm of screening for heart failure by symptoms and NT-proBNP in patients with type 2 diabetes
    Hofer-Zeni, Sarah
    Leutner, Michael
    Klimek, Peter
    Bellach, Luise
    Pavo, Noemi
    Prausmueller, Suriya
    Huelsmann, Martin
    Kautzky-Willer, Alexandra
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [18] Plasma NT-proBNP is independently associated with albuminuria in type 2 diabetes
    Zhou, Lingli
    Cai, Xiaoling
    Li, Minghui
    Han, Xueyao
    Ji, Linong
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (04) : 669 - 674
  • [19] Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP
    Lassus, Johan
    Harjola, Veli-Pekka
    Sund, Reijo
    Siirilae-Waris, Krista
    Melin, John
    Peuhkurinen, Keijo
    Pulkki, Kari
    Nieminen, Markku S.
    EUROPEAN HEART JOURNAL, 2007, 28 (15) : 1841 - 1847
  • [20] Prognostic value of pleural effusion, CA-125 and NT-proBNP in patients with acute decompensated heart failure
    Davutoglu, Vedat
    Yildirim, Cuma
    Kucukaslan, Hasan
    Yuce, Murat
    Sari, Ibrahim
    Tarakcioglu, Mehmet
    Akcay, Murat
    Cakici, Musa
    Ceylan, Nurdan
    Al, Behcet
    KARDIOLOGIA POLSKA, 2010, 68 (07) : 771 - 778
12345